Prediction of metabolic clearance of diclofenac in adjuvant-induced arthritis rats using a substrate depletion assay

References

• Achira M, Totsuka R, Kume T. Decreased activity of hepatic P-glycoprotein in the isolated perfused liver of the adjuvant arthritis rat. Xenobiotica 2002; 32: 963–973
   PubMed Web of Science ®Google Scholar
• Belpaire FM, De Smet F, Chindavijak B, Fraeyman N, Bogaert MG. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat. Fundamentals of Clinical Pharmacology 1989; 3: 79–88
   PubMed Web of Science ®Google Scholar
• Boxenbaum H. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin. Journal of Pharmacokinetics and Biopharmacology 1980; 8: 165–176
   PubMedGoogle Scholar
• Dipasquale G, Welaj P, Rassaert CL. Prolonged pentobarbital sleeping time in adjuvant-induced polyarthritic rats. Research Communications in Chemical Pathology and Pharmacology 1974; 9: 253–264
   PubMedGoogle Scholar
• Fukuyama T, Yamaoka K, Ohata Y, Nakagawa T. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats. Drug Metabolism and Disposition 1994; 22: 479–485
   PubMed Web of Science ®Google Scholar
• Iwatsubo T, Hirota N, Ooie T, Suzuki H, Sugiyama Y. Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics. Biopharmacology and Drug Disposition 1996; 17: 273–310
   PubMed Web of Science ®Google Scholar
• Kawase A, Tsunokuni Y, Iwaki M. Effects of alterations in CAR on bilirubin detoxification in mouse collagen-induced arthritis. Drug Metabolism and Disposition 2007; 35: 256–261
   PubMed Web of Science ®Google Scholar
• King C, Tang W, Ngui J, Tephly T, Braun M. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicology Science 2001; 61: 49–53
   PubMed Web of Science ®Google Scholar
• Komura H, Iwaki M. Nonlinear pharmacokinetics of propafenone in rats and humans: application of a substrate depletion assay using hepatocytes for assessment of nonlinearity. Drug Metabolism and Disposition 2005a; 33: 726–732
   PubMed Web of Science ®Google Scholar
• Komura H, Iwaki M. Pharmacokinetics and metabolism of metoprolol and propranolol in the female DA and female Wistar rat: the female DA rat is not always an animal model for poor metabolizers of CYP2D6. Journal of Pharmacology Science 2005b; 94: 397–408
   PubMed Web of Science ®Google Scholar
• Kumar S, Samuel K, Subramanian R, Braun MP, Stearns RA, Chiu SH, Evans DC, Baillie TA. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide. Journal of Pharmacology and Experimental Therapy 2002; 303: 969–978
   PubMed Web of Science ®Google Scholar
• Laethem ME, Belpaire FM, Wijnant P, Rosseel MT, Bogaert MG. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat. Chirality 1994; 6: 405–410
   PubMed Web of Science ®Google Scholar
• Meunier CJ, Verbeeck RK. Glucuronidation kinetics of R,S-ketoprofen in adjuvant-induced arthritic rats. Pharmacology Research 1999; 16: 1081–1086
   PubMed Web of Science ®Google Scholar
• Morita N, Kusuhara H, Nozaki Y, Endou H, Sugiyama Y. Functional involvement of rat organic anion transporter 2 (Slc22a7) in the hepatic uptake of the nonsteroidal anti-inflammatory drug ketoprofen. Drug Metabolism and Disposition 2005; 33: 1151–1157
   PubMedGoogle Scholar
• Nagao T, Tanino T, Iwaki M. Stereoselective pharmacokinetics of flurbiprofen and formation of covalent adducts with plasma protein in adjuvant-induced arthritic rats. Chirality 2003; 15: 423–428
   PubMed Web of Science ®Google Scholar
• Nath A, Atkins WM. A theoretical validation of the substrate depletion approach to determining kinetic parameters. Drug Metabolism and Disposition 2006; 34: 1433–1435
   PubMed Web of Science ®Google Scholar
• Obach RS. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metabolism and Disposition 1999; 27: 1350–1359
   PubMed Web of Science ®Google Scholar
• Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, MacIntyre F, Rance DJ, Wastall P. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. Journal of Pharmacology and Experimental Therapy 1997; 283: 46–58
   PubMed Web of Science ®Google Scholar
• Obach RS, Reed-Hagen AE. Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach. Drug Metabolism and Disposition 2002; 30: 831–837
   PubMed Web of Science ®Google Scholar
• Pang KS, Rowland M. Hepatic clearance of drugs. I. Theoretical considerations of a ‘well-stirred’ model and a ‘parallel tube’ model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. Journal of Pharmacokinetics and Biopharmacology 1977; 5: 625–653
   PubMedGoogle Scholar
• Piquette-Miller M, Jamali F. Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats. Agents Actions 1992; 37: 290–296
   PubMedGoogle Scholar
• Piquette-Miller M, Jamali F. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay. Pharmacology Research 1993; 10: 294–299
   PubMed Web of Science ®Google Scholar
• Piquette-Miller M, Jamali F. Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis. Drug Metabolism and Disposition 1995; 23: 240–245
   PubMed Web of Science ®Google Scholar
• Pollock SH, Matthews HW, D'Souza MJ. Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats. Drug Metabolism and Disposition 1989; 17: 595–599
   PubMed Web of Science ®Google Scholar
• Projean D, Dautrey S, Vu HK, Groblewski T, Brazier JL, Ducharme J. Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain. Pharmacology Research 2005; 22: 62–70
   PubMedGoogle Scholar
• Seglen PO. Preparation of isolated rat liver cells. Methods in Cell Biology 1976; 13: 29–83
   PubMedGoogle Scholar
• Shibata N, Shimakawa H, Minouchi T, Yamaji A. Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states. Biology and Pharmacology Bulletin 1993; 16: 1130–1135
   PubMed Web of Science ®Google Scholar
• Stierlin H, Faigle JW. Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotica 1979; 9: 611–621
   PubMed Web of Science ®Google Scholar
• Tabata K, Yamaoka K, Fukuyama T, Nakagawa T. Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac. Pharmacology Research 1995; 12: 880–883
   PubMed Web of Science ®Google Scholar
• Toda A, Ishii N, Kihara T, Nagamatsu A, Shimeno H. Effect of adjuvant-induced arthritis on hepatic drug metabolism in rats. Xenobiotica 1994; 24: 603–611
   PubMed Web of Science ®Google Scholar
• Walker KA, Barber HE, Hawksworth GM. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat. Drug Metabolism and Disposition 1986; 14: 482–486
   PubMed Web of Science ®Google Scholar
• Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences, USA 1992; 89: 9784–9788
   PubMed Web of Science ®Google Scholar